Chronic stress is known to contribute to clinical depression (Calcia et al., 2016) and as such there is hope that P2X7 antagonists with good CNS penetration and drug likeliness will proceed into clinical testing as novel mechanisms for mood disorders. The gene discussed is P2RX7; the disease is depressive disorder.